Between 6,000 and 8,000 rare diseases affect an estimated 30 million people in the European Union. An unfortunate feature of rare diseases and complex conditions is the fragmentation of specialist knowledge, which is often not available in the patient´s region or country. Many patients therefore might not receive a satisfactory explanation for their symptoms, have delays to correct diagnosis or have access to the necessary knowledge on treatment options, rehabilitation and care.
That is the reason for the EpiCARE Patient Empowerment WG: they act as EpiCARE patient representatives, they are the voice of patients and produce deliverables to support patients and their families and to facilitate communication between them and the healthcare professionals.
The EpiCARE Patient Empowerment Working Group comprises Patient Advocates who are either leaders in rare and complex epilepsy patient organisations (Associations and/or Federations) or patients themselves, from across the European region.
ERN EpiCARE offers the conditions for patient representatives to work together. The Chair and Co-Chair of the EpiCARE Patient Advocacy Group participate ex officio, at the EpiCARE Executive Committee. Several advocate members are active in several other Working Groups. Patient advocates in the field of the epilepsies also collaborate with the International Bureau for Epilepsy (IBE) and the recently created Epilepsyplus Alliance.
EpiCARE patient advocates, together with medical expert produce Patient Journeys and Leaflets to help patients, which you can find here.
Presentation of the Patient Representative Group Video
The application form is also available in pdf format, as well as the endorsement letter template. Both of these can be downloaded through the links below. Please complete these and return the signed documents to [email protected].
Rare epilepsies and patient’s journey: Patient’s journey describe the health-care pathway, provide a key perspective of those living with a rare disease, and allow for a constructive discussion between clinicians and patients.
Other established collaborations with patient advocacy groups
FundHemi brings together patients and their families in Spain, Italy, Portugal and Latin America who have had to undergo, or are facing, an hemispherotomy.
Hemispherotomy is a type of brain surgery used to treat severe, drug-resistant epilepsy. Following a thorough pre-surgical evaluation that should be performed at expert centres, it is used in children or adults with widespread malformations limited to one hemisphere, often due to conditions present from birth or early childhood (e.g. Hemimegalencephaly; Sturge-Weber syndromes; Rasmussen’s encephalitis; …).